Moreover, pharmacists must contact the patient's prescriber to alert of the change so that monitoring of digoxin levels and therapeutic effect can, if necessary, begin.Interestingly, the Digitek recall notice posted on the North Carolina Board of Pharmacy (NCBOP) web site makes no mention of the Digitek pills marketed under the "UDL" label and distributed by UDL Laboratories, Inc. -- part of Mylan Laboratories, Inc. which also includes Mylan… [read post]